Hepatitis C Medicine
Hepatitis C: Widespread, Yet Curable
Especially When Diagnosed and Treated in a Timely Manner With Direct-acting Antivirals (DAAs).
✨ Direct Antiviral therapies and combination drug treatments help manage chronic conditions effectively, improving the quality of life.
About Hepatitis C
Any inflammation in the liver caused by a virus, drug abuse, or any medical condition is called hepatitis. Hepatitis C is a type of viral hepatitis caused by HCV (virus) which can be transmitted through infected fluids, sharing needles, or from mother to child.
Acute Hepatitis C
It’s a mild infection, generally the initial stages of infection, it can last for 6 months, and can get cured by itself.
Chronic Hepatitis C
It’s the severe form of infection, persisting for a long time, and the body is unable to heal itself, causing severe inflammation and liver damage.
Symptoms & Complications
Early stages may have mild flu-like symptoms (fatigue, abdominal pain, nausea, dark urine). Long term complications include liver fibrosis, liver failure, and liver cancer.
Treatment Choices
Direct Antiviral therapies and combination drug treatments help manage chronic conditions effectively, improving the quality of life.
Treatment Choices for Hepatitis C
Modern direct-acting antiviral drug classes designed to target specific stages of Hepatitis C viral replication.
NS5B Polymerase Inhibitors
NS5B significantly leads to the elimination of the virus by inhibiting replication.
NS5A Inhibitors
NS5A significantly drops the viral load, which inhibits viral assembly and replication, implying a cure.
NS3/4A Protease Inhibitors
NS3/4A Protease inhibitors prevent viral protein processing, transmission, and spread.
Combination Therapies
Safer and highly tolerated regimens combining multiple inhibitors for broad-spectrum antiviral activity.
The Potent Combination Therapies
Highly effective drug combinations offering advanced Hepatitis C treatment with minimal side effects.
Sofosbuvir and Velpatasvir (Velakast)
Offers a broad spectrum of antiviral activity for advanced Hepatitis treatment in pediatric (>3 years) and adult patients. Used for compensated and decompensated cirrhosis (with Ribavirin).
Ledipasvir & Sofosbuvir (Ledikast)
Approved for genotypes 1, 4, 5, and 6. Suitable for pediatric patients of 3 years of age and older, with or without compensated cirrhosis.
Sofosbuvir + Daclatasvir (Sofokast Plus)
Safer, well-tolerated, and has minimal side effects. Recommended for elderly patients with cirrhosis stages 5, 6 or failed direct-acting antivirals.
Glecaprevir + Pibrentasvir / Voxilaprevir
Treats genotypes 1-6 in patients with compensated cirrhosis. Sofosbuvir+Velpatasvir+Voxilaprevir is used for patients with failed DAA treatment.
Hepatitis C Formulations
Showing 9 of 32 medicines
Eltrombo-25 (Eltrombopag 25mg)
Eltrombopag Olamine
Classification- Platelet-stimulating drug
Eltrombo-50 (Eltrombopag 50mg)
Eltrombopag Olamine
Classification: Supportive cancer medicine
Ribasure 200mg (Ribavirin)
Ribavirin
It is the antiviral drug used for Hepatitis C infection.
Teravir
Tenofovir disoproxil fumarate (300mg)
Composition- Tenofovir disoproxil fumarate
Qurled
Sofosbuvir
It is a Sofosbuvir tablet. It is manufactured by Strides Pharma.
Qurdac
Daclatasvir
It is a daclatasvir tablet. It is manufactured by Strides Pharma.
Hepcvel
Sofosbuvir / Velpatasvir
What is Hepcvel ( Sofosbuvir/Velpatasvir) tablet?
MyHep All
Sofosbuvir / Velpatasvir
MyHep All is a combination of sofosbuvir and velpatasvir, manufactured by Mylan.
MyHep LVIR
Sofosbuvir / Ledipasvir
It consists of drugs (Ledipasvir + Sofosbuvir).
Frequently Asked Questions
Find answers to the most common queries regarding Hepatitis C treatments, sourcing, and management.